137 related articles for article (PubMed ID: 17904240)
1. Biodegradable micro-osmotic pump for long-term and controlled release of basic fibroblast growth factor.
Ryu W; Huang Z; Prinz FB; Goodman SB; Fasching R
J Control Release; 2007 Dec; 124(1-2):98-105. PubMed ID: 17904240
[TBL] [Abstract][Full Text] [Related]
2. Long-term and zero-order release of basic fibroblast growth factor from heparin-conjugated poly(L-lactide-co-glycolide) nanospheres and fibrin gel.
Jeon O; Kang SW; Lim HW; Hyung Chung J; Kim BS
Biomaterials; 2006 Mar; 27(8):1598-607. PubMed ID: 16146647
[TBL] [Abstract][Full Text] [Related]
3. Delivery of basic fibroblast growth factor (bFGF) from photoresponsive hydrogel scaffolds.
Andreopoulos FM; Persaud I
Biomaterials; 2006 Apr; 27(11):2468-76. PubMed ID: 16321436
[TBL] [Abstract][Full Text] [Related]
4. Controlled release of fibroblast growth factor 2 stimulates bone healing in an animal model of diabetes mellitus.
Santana RB; Trackman PC
Int J Oral Maxillofac Implants; 2006; 21(5):711-8. PubMed ID: 17066631
[TBL] [Abstract][Full Text] [Related]
5. Acceleration of aneurysm healing by hollow fiber enabling the controlled release of basic fibroblast growth factor.
Kawakami O; Miyamoto S; Hatano T; Yamada K; Hashimoto N; Tabata Y
Neurosurgery; 2006 Feb; 58(2):355-64; discussion 355-64. PubMed ID: 16462490
[TBL] [Abstract][Full Text] [Related]
6. Locally controlled release of basic fibroblast growth factor from multilayered capsules.
Itoh Y; Matsusaki M; Kida T; Akashi M
Biomacromolecules; 2008 Aug; 9(8):2202-6. PubMed ID: 18582120
[TBL] [Abstract][Full Text] [Related]
7. Enhanced angiogenesis through controlled release of basic fibroblast growth factor from peptide amphiphile for tissue regeneration.
Hosseinkhani H; Hosseinkhani M; Khademhosseini A; Kobayashi H; Tabata Y
Biomaterials; 2006 Dec; 27(34):5836-44. PubMed ID: 16930687
[TBL] [Abstract][Full Text] [Related]
8. Heparin conjugated polymeric micelle for long-term delivery of basic fibroblast growth factor.
Lee JS; Go DH; Bae JW; Lee SJ; Park KD
J Control Release; 2007 Feb; 117(2):204-9. PubMed ID: 17196698
[TBL] [Abstract][Full Text] [Related]
9. Bone regeneration with active angiogenesis by basic fibroblast growth factor gene transfected mesenchymal stem cells seeded on porous beta-TCP ceramic scaffolds.
Guo X; Zheng Q; Kulbatski I; Yuan Q; Yang S; Shao Z; Wang H; Xiao B; Pan Z; Tang S
Biomed Mater; 2006 Sep; 1(3):93-9. PubMed ID: 18458388
[TBL] [Abstract][Full Text] [Related]
10. Heparin-functionalized chitosan-alginate scaffolds for controlled release of growth factor.
Ho YC; Mi FL; Sung HW; Kuo PL
Int J Pharm; 2009 Jul; 376(1-2):69-75. PubMed ID: 19450670
[TBL] [Abstract][Full Text] [Related]
11. A device for the spatio-regional delivery of a photocurable drug formulation.
Sonoda H; Yasui H; Matsuda T
Biomaterials; 2004 Jun; 25(14):2859-66. PubMed ID: 14962564
[TBL] [Abstract][Full Text] [Related]
12. In vivo validation of biological responses of bFGF released from microspheres formulated by blending poly-lactide-co-glycolide and poly(ethylene glycol)-grafted-chitosan in hamster cheek pouch microcirculatory models.
Falabella CA; Jiang H; Frame MD; Chen W
J Biomater Sci Polym Ed; 2009; 20(7-8):903-22. PubMed ID: 19454159
[TBL] [Abstract][Full Text] [Related]
13. Photo-crosslinkable and biodegradable Pluronic/heparin hydrogels for local and sustained delivery of angiogenic growth factor.
Yoon JJ; Chung HJ; Park TG
J Biomed Mater Res A; 2007 Dec; 83(3):597-605. PubMed ID: 17503533
[TBL] [Abstract][Full Text] [Related]
14. Induction of new bone by basic FGF-loaded porous carbonate apatite implants in femur defects in rats.
Keiichi K; Mitsunobu K; Masafumi S; Yutaka D; Toshiaki S
Clin Oral Implants Res; 2009 Jun; 20(6):560-5. PubMed ID: 19515035
[TBL] [Abstract][Full Text] [Related]
15. A robust, electrochemically driven microwell drug delivery system for controlled vasopressin release.
Chung AJ; Huh YS; Erickson D
Biomed Microdevices; 2009 Aug; 11(4):861-7. PubMed ID: 19353273
[TBL] [Abstract][Full Text] [Related]
16. Release of basic fibroblast growth factor from a crosslinked glycosaminoglycan hydrogel promotes wound healing.
Liu Y; Cai S; Shu XZ; Shelby J; Prestwich GD
Wound Repair Regen; 2007; 15(2):245-51. PubMed ID: 17352757
[TBL] [Abstract][Full Text] [Related]
17. Intracoronary and intravenous administration of basic fibroblast growth factor: myocardial and tissue distribution.
Laham RJ; Rezaee M; Post M; Sellke FW; Braeckman RA; Hung D; Simons M
Drug Metab Dispos; 1999 Jul; 27(7):821-6. PubMed ID: 10383927
[TBL] [Abstract][Full Text] [Related]
18. Resonance energy transfer for assessing the molecular integrity of proteins for local delivery.
Wu D; Edelman ER
Biotechnol Bioeng; 2004 Feb; 85(4):406-12. PubMed ID: 14755558
[TBL] [Abstract][Full Text] [Related]
19. Research on promoting periodontal regeneration with human basic fibroblast growth factor-modified bone marrow mesenchymal stromal cell gene therapy.
Tan Z; Zhao Q; Gong P; Wu Y; Wei N; Yuan Q; Wang C; Liao D; Tang H
Cytotherapy; 2009; 11(3):317-25. PubMed ID: 19308772
[TBL] [Abstract][Full Text] [Related]
20. Microchips and controlled-release drug reservoirs.
Staples M
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2010; 2(4):400-17. PubMed ID: 20564466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
